| |
Antex Biologics Unveils New World Wide Web Site; Deloitte & Touche
Lists Antex 62nd Fastest-Growing U.S. Technology Company in 1997
GAITHERSBURG, Md., March 3 /PRNewswire/ -- Antex Biologics (OTC Bulletin Board: ANTX - news)
announces the launch of its new World Wide Web site, found at antexbiologics.com.
''Antex is excited about tapping into the global access provided by the World Wide Web to bring to the world news
of our innovations to fight infectious disease,'' said Dr. Vic Esposito, Chairman and CEO of Antex. ''We hope our
site will be useful to a wide range of visitors, including scientists, reporters and researchers, as well as investors
and analysts, from all over the world.''
In addition to information about the Company's proprietary technologies, product pipeline, and common stock, the
new web site contains statistics and descriptions of seven human pathogens for which the Company is developing
vaccines and therapeutics. These pathogens include: Helicobacter pylori, Campylobacter jejuni, Haemophilus
influenzae (nontypeable), and Chlamydia trachomatis.
Antex Joins Fast 500
Today's launch of the new Web site follows Deloitte & Touche's announcement that Antex is the 62nd fastest
growing U.S. company in the national Technology Fast 500.
The Technology Fast 500 is an awards program that ranks U.S. technology companies by percentage growth in
revenue over a five-year period. To qualify, companies must have been in business for five years, and must be
developing and/or providing technology products or services, according to a Deloitte & Touche press release.
Antex's revenues have increased over 4,000 percent in the last five years.
Antex Biologics is a biopharmaceutical company committed to improving human health by developing new products
to prevent and treat infectious diseases and related disorders. The Company has three vaccine products in clinical
development and has strategic alliances with SmithKline Beecham, Pasteur Merieux Connaught, and the U.S. Navy.
The Company's common stock is quoted on the OTC Bulletin Board under the ticker symbol ANTX.
SOURCE: Antex Biologics |
|
